Haemonetics Corporation (HAE) Completes Hemerus Medical, LLC Acquisition
5/1/2013 9:48:51 AM
More...
|
Haemonetics Corporation (HAE) Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance
5/1/2013 6:29:33 AM
More...
|
Hemerus Medical, LLC's SOLX Red Blood Cell Additive Receives World's First CE Marking
9/18/2012 6:53:09 AM
More...
|